LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
 31.62 84.90 183 2449 0.0747 0.1716
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 31.62 84.90 2001 2449 0.8168 0.9183
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 33.32 84.90 220 2722 0.0808 0.2096
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 33.32 84.90 2229 2722 0.8188 0.9216
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 33.32 84.90 215 2722 0.0790 0.2041
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 33.32 84.90 2119 2722 0.7784 0.9023
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 35.03 84.90 259 2991 0.0866 0.2424
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 35.03 84.90 2389 2991 0.7987 0.9144
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 35.03 84.90 251 2991 0.0839 0.2348
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 35.03 84.90 2344 2991 0.7836 0.9073
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 36.73 84.90 304 3254 0.0934 0.2744
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 36.73 84.90 2597 3254 0.7980 0.9160
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 36.73 84.90 293 3254 0.0900 0.2655
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 36.73 84.90 2541 3254 0.7808 0.9081
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 38.43 84.90 384 3459 0.1110 0.3260
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 38.43 84.90 2771 3459 0.8010 0.9187
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 38.43 84.90 324 3459 0.0937 0.2845
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 38.43 84.90 2727 3459 0.7882 0.9130
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 40.14 84.90 400 3682 0.1086 0.3298
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 40.14 84.90 2959 3682 0.8036 0.9212
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 40.14 84.90 402 3682 0.1092 0.3310
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 40.14 84.90 2920 3682 0.7930 0.9165
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 41.84 84.90 494 4003 0.1234 0.3727
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 41.84 84.90 3190 4003 0.7969 0.9200
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 41.84 84.90 467 4003 0.1167 0.3589
MN20160318_Q02
D18